Outcome of AML Patients with IDH1 or IDH2 Mutations from Diagnosis and Refractory/Relapse Phase of the Disease in Routine Practice

被引：1
|
作者：
Bertoli, Sarah [1 ]
Tavitian, Suzanne [1 ]
Delabesse, Eric [2 ,3 ]
Sarry, Audrey [1 ]
Huguet, Francoise [1 ]
Recher, Christian [1 ,4 ]
机构：
[1] Inst Univ Canc Toulouse Oncopole CHU Toulouse, Serv Hematol, Toulouse, France
[2] CHU Toulouse, Laboratoire Hematol, Toulouse, France
[3] CNRS, Hematol Lab, ERL5294, UMR1037 INSERM, Toulouse, France
[4] CNRS, Ctr Recherches Cancerol Toulouse, ERL5294, UMR1037 INSERM, Toulouse, France
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1718.1718
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1718
引用
收藏
页数：6
相关论文
共 50 条
  • [1] IDH1 and IDH2 Mutations in Gliomas, AML, and Intrahepatic Cholangiocarcinoma
    Wachsmann, M. B.
    Hatanpaa, J.
    Chen, W.
    Hammer, S.
    Ram, R.
    Oliver, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1031 - 1032
  • [2] IDH1/IDH2 mutations predict survival in glioma and AML
    Hegi, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S2 - S2
  • [3] IDH1 and IDH2 Mutations in Chondrosarcomas
    Nafa, K.
    Agaram, N. P.
    Borsu, L.
    Schwartz, G.
    Healey, J.
    Ladanyi, M.
    Hameed, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 700 - 700
  • [4] IDH1 (BUT NOT IDH2) MUTATIONS CAUSE INFERIOR OUTCOME IN PATIENTS WITH AML WITH AN INTERMEDIATE-RISK CYTOGENETICS
    Markova, J.
    Michkova, P.
    Salek, C.
    Brezinova, J.
    Maaloufova, J. Soukupova
    Soukup, P.
    Cetkovsky, P.
    Michalova, K.
    Schwarz, J.
    HAEMATOLOGICA, 2015, 100 : 371 - 371
  • [5] IDH1 and IDH2 Mutations in Gliomas
    Adam L. Cohen
    Sheri L. Holmen
    Howard Colman
    Current Neurology and Neuroscience Reports, 2013, 13
  • [6] IDH1 and IDH2 Mutations in Gliomas
    De Carli, Emilie
    Wang, Xiaowei
    Puget, Stephanie
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (21): : 2248 - 2248
  • [7] IDH1 and IDH2 Mutations in Gliomas
    Cohen, Adam L.
    Holmen, Sheri L.
    Colman, Howard
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (05)
  • [8] IDH1 and IDH2 Mutations in Gliomas
    Yan, Hai
    Parsons, D. Williams
    Jin, Genglin
    McLendon, Roger
    Rasheed, B. Ahmed
    Yuan, Weishi
    Kos, Ivan
    Batinic-Haberle, Ines
    Jones, Sian
    Riggins, Gregory J.
    Friedman, Henry
    Friedman, Allan
    Reardon, David
    Herndon, James
    Kinzler, Kenneth W.
    Velculescu, Victor E.
    Vogelstein, Bert
    Bigner, Darell D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (08): : 765 - 773
  • [9] AML patients with IDH1 or IDH2 mutations treated with hypomethylating agents: A case series
    Benton, Christopher Brent
    Ravandi, Farhad
    Andreeff, Michael
    Kantarjian, Hagop
    Konopleva, Marina
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] INCIDENCE AND TYPE OF IDH1 AND IDH2 MUTATIONS IN AML-NK PATIENTS AND THEIR PROGNOSTIC IMPACT ON TREATMENT OUTCOME
    Kim, H. J.
    Kim, Y. K.
    Kook, H.
    Lee, I. K.
    Kim, N.
    Kim, D. D. H.
    Kim, H. J.
    Jung, C. W.
    Jang, J. H.
    Moon, J. H.
    Sohn, S. K.
    Won, J. H.
    Kim, S. H.
    Huh, J.
    Jung, S. H.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    HAEMATOLOGICA, 2014, 99 : 298 - 299
12345